SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001587221-20-000039
Filing Date
2020-11-13
Accepted
2020-11-13 16:08:07
Documents
15
Period of Report
2020-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zsan-20201112.htm   iXBRL 8-K 41842
2 EX-99.1 q320exhibit991.htm EX-99.1 90637
  Complete submission text file 0001587221-20-000039.txt   288207

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20201112.xsd EX-101.SCH 2435
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zsan-20201112_cal.xml EX-101.CAL 718
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zsan-20201112_def.xml EX-101.DEF 1651
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20201112_lab.xml EX-101.LAB 24975
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20201112_pre.xml EX-101.PRE 13195
8 EXTRACTED XBRL INSTANCE DOCUMENT zsan-20201112_htm.xml XML 11189
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 201311542
SIC: 2834 Pharmaceutical Preparations